Pitts, Nigel B.
Zero, Domenick T.
Marsh, Phil D.
Ekstrand, Kim
Weintraub, Jane A.
Ramos-Gomez, Francisco
Tagami, Junji
Twetman, Svante
Tsakos, Georgios
Ismail, Amid
Article History
First Online: 25 May 2017
Competing interests
: N.B.P. has received honoraria and corporate and social responsibility support from Colgate, consultation fees from Calcivis and holds stock in a King's College London spin-out, Reminova. D.T.Z. has received contracted research funding from Johnson & Johnson, GlaxoSmithKline, C3-Jian and Noveome Biotherapeutics. All other authors declare no conflicts of interest.